Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled Trial of Atrioventricular (AV) Junction Ablation and Biventricular Pacing Versus Optimal Pharmacological Therapy in Patients With Permanent Atrial Fibrillation

NCT02137187 is registered in ClinicalTrials.gov with Centro Prevenzione Malattie Cardiovascolari N. e V. Corbella as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02137187 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled Trial of Atrioventricular (AV) Junction Ablation and Biventricular Pacing Versus Optimal Pharmacological Therapy in Patients With Permanent Atrial Fibrillation
Lead sponsor
Centro Prevenzione Malattie Cardiovascolari N. e V. Corbella
Phase
Phase 3
Overall status
Unknown status
Start date
October 15, 2014
Completion date
July 31, 2021
Enrollment
1,830 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

permanent atrial fibrillation